Supportive oligonucleotide (SOT) therapy

Longevity Medicine
Supportive oligonucleotide (SOT) therapy, a cutting-edge approach in the field of gene silencing, has garnered significant attention for its potential in treating various disorders. This innovative therapeutic strategy involves the use of short sequences of nucleotides, known as oligonucleotides, to modulate gene expression and address underlying genetic abnormalities.

Single Infusions Start at $2000

QUICK FACTS

FREQUENCY
Fill in text

TREATMENT TIME
Fill in text

need headline

SOT Therapy presents a tailored approach to combat cancer, viruses, and pathogens like Lyme Disease. This therapy targets a specific gene associated with the malignant cell or pathogen, disrupting crucial processes that support their survival or growth. In the course of treatment, the patient’s blood is examined, and a customized oligonucleotide sequence is crafted to impede the cells’ survival or growth. RGCC SOTs are exclusively accessible to RGCC Network doctors.

How Supportive Oligonucleotide (SOT) Therapy Works:

SOT Therapy, categorized as an gene silencing or antisense therapy, is meticulously crafted to influence a specific RNA sequence in viruses, bacteria, pathogens, or malignant cells. Antisense oligonucleotides (ASOs) or small interfering RNA (siRNA) can be designed to target specific pathogenic or malignant RNA and inhibit replication. This slowdown gives the immune system a chance to recover and better handle the infection as well.

Various mechanisms are employed in Supportive oligonucleotide (SOTtherapy for gene silencing. Antisense oligonucleotides, for instance, are designed to bind to specific RNA molecules, blocking their normal function and preventing the synthesis of disease-related proteins. Another approach involves the use of small interfering RNA (siRNA), which triggers the degradation of specific mRNA molecules, thereby inhibiting the translation of genetic information into proteins.

One of the key advantages of Supportive Oligonucleotide therapy lies in its specificity. Unlike traditional treatments that may affect multiple genes or pathways, this approach allows for a highly targeted intervention. This precision minimizes the risk of unintended side effects and enhances the therapeutic potential of the treatment.

In the context of EBV, SOT Therapy aims to harness the power of oligonucleotides to selectively target and silence specific viral genes or elements essential for the virus’s replication and survival. This approach leverages the principles of gene silencing to interfere with the expression of viral genes, ultimately inhibiting the virus’s ability to infect and replicate within host cells.

Supportive Oligonucleotide Therapy (SOT) for Lyme disease holds promise as a targeted approach to combat the bacterial infection caused by Borrelia burgdorferi. This innovative therapy utilizes oligonucleotides to selectively interfere with essential bacterial genes, aiming to disrupt the pathogen’s survival and replication within the host. Antisense oligonucleotides (ASOs) or small interfering RNA (siRNA) can be designed to target specific bacterial RNA, hindering the synthesis of crucial proteins required for the bacterium’s viability.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680246/

https://projectlyme.org/Supportive-oligonucleotide-therapy-sot-for-lyme/

Supportive Oligonucleotide Therapy (SOT) for cancer represents a groundbreaking approach in the realm of precision medicine. This therapeutic strategy involves using oligonucleotides, such as antisense oligonucleotides (ASOs) or small interfering RNA (siRNA), to selectively target and silence specific genes associated with cancer. By disrupting the expression of key oncogenes or signaling pathways, SOT Therapy aims to inhibit tumor growth and progression. The specificity of this approach minimizes collateral damage to healthy cells, potentially reducing side effects compared to traditional cancer treatments. Ongoing research and clinical trials are exploring the feasibility of SOT Therapy for various cancer types, with a focus on optimizing delivery methods and ensuring the safety and efficacy of this innovative therapy in the complex landscape of cancer treatment.

Soul-Centered Healthcare As a Catalyst For Change

Many people suffer with undiagnosed or misdiagnosed conditions and simply don’t know what’s wrong with them or what will help.  We understand what it’s like to feel trapped in a body that is not working for you! At Meeting Point Health, we find the root cause and use a proven, integrative approach that gets results.  As highly trained pioneers in functional and regenerative medicine, we’ve helped thousands of patients take control of their health.

OUR PATIENTS FIND RELIEF HERE

Our Patients Find Relief Here

We’re here to answer all of your questions

At Meeting Point, we understand that every condition stems from an imbalance elsewhere in the body. We aim to find and heal that imbalance so you can live a richer, healthier life.

Call to schedule your initial consultation with one of our expert healthcare providers if you’re ready to experience what compassionate, holistic care can do for you.

Once the blood has been tested and verified for a specific pathogen or cancer, the SOT injection is processed and made at the RGCC laboratories. Once delivered to our clinic, the SOT is given via infusion over 1-3 hours. Patients should do no other therapies 2 weeks before and 1 month after SOT to allow for scavenging and targeting of specific cells. Typically, 1-3 infusions are needed, depending on the case. Total effectiveness is reached between 6-9 months.

Meeting Point Health does not accept insurance.

Our practitioners and staff fully understand and empathize with the challenges that patients face as they make financial decisions for proper health care. Our practice is very different from a conventional medical practice in many ways, but the time spent with each patient is usually 30-90 minutes. Visits with a physician covered by insurance generally allow for less than 10 minutes in total! Conventional medical practices that take insurance maintain brief office visits and high patient loads for this reason. We cannot provide the expert care that every one of our patients deserves under those circumstances.

Insurance also dictates the types of treatments and order of treatments patients can receive for a particular condition.

Opting out of insurance allows the patient and the doctor to maintain their medical autonomy, which is imperative to ensure you get the right treatment at the right time and the right dose.

To start your journey to relief, schedule a consultation with our team. During your initial visit, we’ll assess your medical history, perform a thorough evaluation, and develop a customized treatment plan to address your specific needs. Click to schedule a free discovery call with one of our Patient Onboarding Specialists today!

fast-track your health with regenerative orthopedics

request your appointment today!